Persistent Low Viremic Relapse vs High Viremic Relapse After the End of Treatment With Bulevirtide With or Without Pegylated Interferon in Patients With Chronic Hepatitis Delta Virus

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


Persistent Low Viremic Relapse vs High Viremic Relapse After the End of Treatment With Bulevirtide With or Without Pegylated Interferon in Patients With Chronic Hepatitis Delta Virus

	AASLD 2025 Nov 7-11 Wash DC Fabien Zoulim